
Advances in Cancer Research
Description
Alles über E-Books | Antworten auf Fragen rund um E-Books, Kopierschutz und Dateiformate finden Sie in unserem Info- & Hilfebereich.
More details
Other editions
Additional editions

Content
- Cover
- Advanced in Cancer Research
- Copyright
- Contents
- Contributors
- Is Survivin the Potential Achilles' Heel of Cancer?
- Introduction
- Survivin, A Member of the Inhibitors of Apoptosis Protein Family
- Cell Biology Of Survivin
- Regulation of Survivin Expression
- The Multiple Functions of Survivin
- Molecular Targeting of Survivin in Cancer Therapy
- Survivin As A Generic Tumor-Associated Antigen
- Immune Recognition of Survivin
- Experimental Vaccines Targeting Survivin
- Dendritic Cell-Based Vaccines
- Naked Dna Vaccines
- Survivin-Based Vaccines in the Clinic
- Potential Pitfalls Associated With Survivin-Based Th erapies
- Survivin Expression in Nontransformed Adult Tissues
- Oncogenic Potential Associated with Survivin Gene Transfer
- Risks of Autoimmunity
- Concluding Remarks
- Acknowledgments
- References
- The Essential Role of Evasion from Cell Death in Cancer
- Introduction To Apoptosis Signaling
- The Bcl-2 family regulated apoptotic pathway
- Interactions between the different subgroups of the Bcl-2 family regulate apoptosis
- Functions and regulation of the prosurvival Bcl-2 proteins
- The control of prosurvival Bcl-2 family member expression and function
- Functions and regulation of the multi-BH domain proapoptotic Bax/Bak proteins
- Functions and regulation of the BH3-only proteins
- Chromosomal Translocations that Cause Abnormal Overexpression of the Bcl-2 Prosurvival Proteins in Cancer
- Copy-Number Variations In Bcl-2 Family Prosurvival Genes In Cancer
- Expression Of Bcl-2 Prosurvival Proteins In Cancer
- Role Of Bcl-2 Prosurvival Proteins For The Development And Sustained Growth Of Cancers
- Expression Of Viral Bcl-2 Prosurvival Proteins In Cancer
- Potential Therapies Based On Neutralizing Prosurvival Bcl-2 Proteins
- Acknowledgments
- References
- Faulty Epithelial Polarity Genesand Cancer
- Introduction
- Building Blocks of Epithelial Polarity
- Cell Polarity in Normal Epithelial Function
- Epithelial Cell Junctions
- Tight Junctions
- Adhesion and Desmosomal Junctions
- Hemidesmosomes and Basement Membrane
- Molecular Machinery for Maintenance of Polarity
- Segregation and Reciprocal Inhibition of Polarity Complexes
- Lipid Signaling
- Protein Sorting and Trafficking
- Core Polarity Complexes
- Par
- Par Genes in Polarity Regulation
- Apical Players: Par3, Par6, aPKC
- Lateral and Center Players: Par1, Par5
- Tumor Suppressor Gene LKB1/Par4
- Crumbs
- Scrib
- Enzymatic Polarity Control
- Rho GTPases CDC42, RAC1, and RHOA
- RHO GTPases in Control of Adhesion Junctions
- Crosstalk between RHO GTPases, and PAR and CRB Complexes in Control of Apical Domain
- RHO GTPases, Polarity, and Microenvironment
- Serine/Threonine Protein Kinase apkc and Lipid Kinase pi3k
- aPKC
- PI3K
- Type II Transmembrane Serine Proteases
- Matriptase
- Glycosylphosphatidylinositol (GPI)-Anchored Prostasin
- Hepsin
- Epithelial Polarity Genes and Cancer
- Neoplastic and Hyperplastic Tumor Suppressor Genes
- Polarity Genes in Human Cancer
- PAR6 and par3 in Cancer
- aPKC in Cancer
- LKB1 in Cancer
- Crumbs in Cancer
- Scribble in Cancer
- Rho GTPase Dysregulation in Cancer
- Pi3k and Pten in Cancer
- Matriptase, Prostasin, and Hepsin in Cancer
- Epithelial Polarity Mechanisms as Therapeutic Target
- Reversion of Malignant Epithelium
- RHO GTPases, Reversion of Ras Transformation and Inhibitors
- Integrins, Reversion of Transformation and Inhibitors
- Pi3k, Reversion of Transformation and Inhibitors
- Targeting Pathways Coupling Polarity with Proliferation and Apoptosis
- Polarity Proteins and Cell Proliferation
- apkc Inhibitors
- Ttsp Inhibitors
- Matriptase Inhibitors
- Hepsin Inhibitors
- Polarity Proteins and Apoptosis
- Acknowledgments
- References
- Adult T Cell Leukemia/Lymphoma: FoxP3+ Cells and the Cell-Mediated Immune Response to HTLV-1
- IntroductionPlease check the order of section headings for correctness.
- Adult T Cell Leukemia/Lymphoma
- Cellular Immune Response To Htlv-1
- foxp3 and regulatory t cells
- What is the Frequency of FoxP3 Expression in Nonmalignant HTLV-1 Infection (Toulza et al., 2008)?
- Do CD4+ FoxP3+ T Cells Act as Tregs in HTLV-1 Infection (Toulza et al., 2008)?
- What is the Frequency of FoxP3+ Cells in ATLL (Toulza et al., 2009)?
- Do FoxP3+ Cells in Cases of ATLL Act as Tregs (Toulza et al., 2009)?
- What Causes the High Frequency of FoxP3+ Cells in HTLV-1 Infection (Toulza et al., 2010)?
- Conclusions
- Acknowledgments
- References
- Index
System requirements
File format: PDF
Copy protection: Watermark-DRM (Digital Rights Management)
System requirements:
- Computer (Windows; MacOS X; Linux): Use the free software Adobe Reader, Adobe Digital Editions, or any other PDF viewer of your choice (see eBook Help).
- Tablet/Smartphone (Android; iOS): Install the free app Adobe Digital Editions or another reading app for eBooks, e.g., PocketBook (see eBook Help).
- E-reader: Bookeen, Kobo, Pocketbook, Sony, Tolino and many more (only limited: Kindle).
The file format PDF always displays a book page identically on any hardware. This makes PDF suitable for complex layouts such as those used in textbooks and reference books (images, tables, columns, footnotes). Unfortunately, on the small screens of e-readers or smartphones, PDFs are rather annoying, requiring too much scrolling.
This eBook uses Watermark-DRM, a „soft” copy protection. This means that there are no technical restrictions to prevent illegal distribution. However, there is a personalised watermark embedded in the eBook that can be used to identify the purchaser of the eBook in the event of misuse and to provide evidence for legal purposes.
For more information, see our eBook Help page.